Neuronal PGC-1alpha evidence separates synaptic maintenance and alpha-synuclein vulnerability from generic biogenesis claims

**Background:** PGC-1alpha is often treated as a generic mitochondrial-biogenesis or neuroprotection marker in neuronal work, but that framing can merge synaptic structure, local mitochondrial support, cortical stress adaptation, alpha-synuclein toxicity and dopamine-neuron survival into one claim. **Objective:** This working paper tests whether public primary neuronal evidence better supports a compartment- and stress-state gate: PGC-1alpha-linked synaptic-maintenance and alpha-synuclein-vulnerability endpoints should be separated from generic mitochondrial content or broad survival claims. **Methods:** PubMed, PubMed Central, publisher records and author pages were searched on 2026-10-09 for primary studies linking neuronal PGC-1alpha to dendritic spines, mitochondrial support, serotonin/SIRT1 recruitment, alpha-synuclein vulnerability, alpha-synuclein oligomerization, dopamine-neuron survival and human PD substantia nigra markers. Five complete public primary-source texts were archived, hashed and coded by neuron context, perturbation, endpoint class, directly supported link, boundary condition and competing-model implication. Endpoint classes were synaptic/local bioenergetic, cortical stress adaptation, alpha-synuclein vulnerability, oligomerization and dopamine-neuron survival. No pooled estimate, clinical efficacy claim or causal proof across all neuronal contexts was attempted. **Results:** The coded evidence supports endpoint separation rather than a single generic-health interpretation. Hippocampal PGC-1alpha knockdown reduced dendritic mitochondrial and synaptic endpoints while reported controls separated the spine phenotype from overt neurodegeneration [1]. Cortical serotonin/5-HT2A stimulation recruited a SIRT1-PGC-1alpha-associated mitochondrial program with ATP, respiration, ROS and stress-survival endpoints [2]. Nigral alpha-synuclein models linked PGC-1alpha activity to ER-mitochondria organization, respiration, oxidative detoxification and alpha-synuclein vulnerability without requiring a simple overall mitochondrial-density decrease [3]. A separate alpha-synuclein oligomerization study supported oligomer/toxicity endpoints as a proteinopathy lane [4]. Adult dopamine-neuron PGC-1alpha knockout provided the key boundary: late or vulnerable nigral contexts can become survival-relevant, so the gate is not a synapse-only claim [5]. **Conclusions:** Public primary evidence supports a bounded research claim: in mature hippocampal and vulnerable dopaminergic contexts, PGC-1alpha-linked neuronal outcomes should be measured as compartmental synaptic maintenance, stress adaptation, alpha-synuclein vulnerability and survival layers rather than inferred from bulk mitochondrial-biogenesis or cell-death markers alone. Confirmation would change future study design by requiring matched synaptic, local mitochondrial, ER-mitochondria, oxidative-stress, alpha-synuclein and viability readouts before PGC-1alpha is called a generic neuronal protection target.